N05.2
Unspecified nephritic syndrome with diffuse membranous glomerulonephritis
Clinical Classification Guidelines
Medical Intelligence & Overview
Unspecified nephritic syndrome with diffuse membranous glomerulonephritis is a kidney condition characterized by inflammation of the glomeruli—the tiny filtering units within the kidneys. When this condition is classified as 'unspecified,' it indicates that specific details about the type or cause of the nephritic syndrome are not identified. Diffuse membranous glomerulonephritis is a specific form where thickening of the glomerular basement membrane occurs uniformly across the kidneys, leading to disruptions in filtering blood properly. This condition can affect kidney function and potentially progress to more severe kidney diseases if not managed appropriately.
Causes & Symptoms
Clinical Causes: Autoimmune diseases, such as systemic lupus erythematosus Infections, including hepatitis B and C Certain medications or toxins Malignancies in some cases Genetic factors that predispose individuals to kidney inflammation
Key Symptoms: Edema, especially in the legs, ankles, or around the eyes Foamy or bubbly urine due to proteinuria High blood pressure Fatigue and general feeling of malaise Reduced urine output or dark-colored urine Unintentional weight loss in some cases
Diagnostic & Treatment
Diagnosis Path: To diagnose this condition, healthcare providers typically use a combination of tests and examinations, including: - Urinalysis to detect protein, blood, or other abnormalities in the urine - Blood tests to evaluate kidney function and immune activity - Kidney biopsy, where a small tissue sample is examined under a microscope to identify changes in glomeruli - Imaging studies may be used to assess kidney size and structure These diagnostics help determine the presence of nephritic syndrome and specify the pattern of glomerular damage.
Treatment Protocols: While specific treatments should always be tailored by a healthcare professional, general approaches for managing this condition include: - Immunosuppressive medications to reduce inflammation and immune response - Blood pressure control with antihypertensive drugs, especially agents that reduce protein loss - Diuretics to manage swelling and fluid retention - Dietary modifications, such as reduced salt intake and balanced protein consumption - Regular monitoring of kidney function and protein levels in urine In some cases, additional therapies such as plasmapheresis or medications targeting underlying causes may be necessary. Early detection and appropriate management are vital to prevent progression to chronic kidney disease or kidney failure.
Clinical Advice & FAQs
Billing Guidance
Is N05.2 a billable ICD-10 code?
Yes, N05.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N05.2?
Clinical documentation must specify the nature of Unspecified nephritic syndrome with diffuse membranous glomerulonephritis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference